Source link : https://newshealth.biz/health-news/sglt2i-improves-outcomes-after-tavi/
(MedPage Today) — CHICAGO — Dapagliflozin (Farxiga) lowered mortality and heart failure worsening in high-risk older adults getting transcatheter aortic valve implantation (TAVI), the DapaTAVI trial showed. In a population with a history of… Source link : https://www.medpagetoday.com/meetingcoverage/acc/114884 Author : Publish date : 2025-03-29 18:43:00 Copyright for syndicated content belongs to the linked Source.
The post SGLT2i Improves Outcomes After TAVI first appeared on News Health.
Author : News Health
Publish date : 2025-03-29 18:43:00
Copyright for syndicated content belongs to the linked Source.